| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9e5ac09d7a83e24a7906faa9be8c3b00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C279-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-235 |
| filingDate |
1994-07-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_581c7be6def8c1812757351c2798ac07
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8e930bc3c953e0159eb36b57242c07aa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_071a63f64462a4f0983759adda961b6a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a14762c36b6aae71c902ca883f261dfb |
| publicationDate |
1996-01-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-H0820570-A |
| titleOfInvention |
Alpha-substituted propionate compound |
| abstract |
(57) [Summary] (Modified) [Structure] Expression (Wherein R -CH 3 or -C 2 H shows the 5) gastrointestinal absorption can be alpha-substituted propionic acid ester compound represented by the. [Effect] These compounds have the property of inhibiting the activity of proteolytic enzymes, especially trypsin and blood trypsin. Therefore, it can be used for the treatment of various symptoms caused by abnormal trypsin activity in blood. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2253612-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-115141124-A |
| priorityDate |
1994-07-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |